Onze website gebruikt cookies zodat we je de beste gebruikerservaring kunnen geven. Door onze website te bekijken, ga je akkoord met het gebruik van deze cookies. Lees meer
Neogene Therapeutics is a pre-clinical stage biotechnology company aiming to change the paradigm of treatment for solid cancers. Our mission is to provide cancer patients with T cell therapies targeting mutated proteins called neo-antigens, which present in cancerous tissue as a consequence of DNA mutations. In a process that is minimally invasive for the patient, Neogene intends to leverage technology to engineer “Designer T cells” with optimized ability to seek and destroy tumor cells based on neo-antigens.